Answers are grounded in this paper and cite their sources.
Introduction. Vitamin D reduces illness-related inflammation and boosts the immune system. COVID-19 has aroused debate and requires substantial scientific research to produce an effective defence against distinct coronavirus strains. In COVID-19 patients, vitamin D and C‑reactive protein levels were compared. Three months before the PCR test, vitamin D and C-reactive protein levels were assessed. These individuals' clinical results were also examined. Aim. Investigation of the ability of vitamin D to mitigate C‑reactive protein levels in individuals with COVID-19 Materials and Methods. For the purpose of this cohort study, instances of COVID-19 were analyzed and differentiated into four distinct groups according to the levels of vitamin D that they possessed. Groups I through IV were classified according to the following parameters: concentration of 0–10 ng/ml, 10–20 ng/ml, 20–30 ng/ml, and greater than 30 ng/ml. These values served as the basis for the categorization of the samples. In order to determine the levels of vitamin D and C-reactive protein, the study used a method that had been clinically verified and was also automated. Results. The prevalence of COVID-19 was highest in the vitamin D-deficient group. Higher vitamin D levels were associated with reduced COVID-19 severity, a positive correlation with lymphocyte proportion, and a negative correlation with white blood cells and CRP. Conclusion. Vitamin D levels are inversely correlated with CRP levels and disease severity in COVID-19 patients. Vitamin D may serve as a potential biomarker for monitoring COVID-19 progression and warrants further investigation for its therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Hallab et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: